Comer E, Duvall JR, Lee M duP. Utilizing diversity-oriented synthesis in antimicrobial drug discovery. Future Med Chem. 2014;6(17):1927-42. doi:10.4155/fmc.14.111.
Duvall JR, Bedard L, Naylor-Olsen AM, et al. Identification of Highly Specific Diversity-Oriented Synthesis-Derived Inhibitors of Clostridium difficile. ACS Infect Dis. 2017;3(5):349-359. doi:10.1021/acsinfecdis.6b00206.
Pane K, Cafaro V, Avitabile A, et al. Identification of Novel Cryptic Multifunctional Antimicrobial Peptides from the Human Stomach Enabled by a Computational-Experimental Platform. ACS Synth Biol. 2018;7(9):2105-2115. doi:10.1021/acssynbio.8b00084.
Rundell EA, Banta LM, Ward DV, Watts CD, Birren B, Esteban DJ. 16S rRNA gene survey of microbial communities in Winogradsky columns. PLoS One. 2014;9(8):e104134. doi:10.1371/journal.pone.0104134.
Nau GJ, Richmond JFL, Schlesinger A, Jennings EG, Lander ES, Young RA. Human macrophage activation programs induced by bacterial pathogens. Proc Natl Acad Sci U S A. 2002;99(3):1503-8. doi:10.1073/pnas.022649799.
Reck F, Alm R, Brassil P, et al. Novel N-linked aminopiperidine inhibitors of bacterial topoisomerase type II: broad-spectrum antibacterial agents with reduced hERG activity. J Med Chem. 2011;54(22):7834-47. doi:10.1021/jm2008826.